In addition, NIK has been implicated in the regulation of breast cancer stem cells, while its inhibition can impair clonogenicity and tumorigenesis, not only through the activation of NF-κΒ, but also through the activation of the ERK1/2 pathway47. Here, MAPK3 is linked to breast carcinoma.